Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214120 · ClinicalTrials.gov registry record
Does Modified Ultrafiltration Affect Thromboelastography Results?
A clinical trial of Congenital Heart Disease, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT03214120 is a study of Congenital Heart Disease that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 40 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03214120, a study of Congenital Heart Disease, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to evaluate the effect of modified ultrafiltration on different components of Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary bypass.
Conditions Studied
Study Locations (1)
Illinois
- Advocate Children's Hospital - Oak Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2019-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03214120
The ClinicalTrials.gov registry entry for NCT03214120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03214120 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03214120 about?
NCT03214120 is a clinical study titled "Does Modified Ultrafiltration Affect Thromboelastography Results?". The study is to evaluate the effect of modified ultrafiltration on different components of Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary bypass.
What is the current status of trial NCT03214120?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-01-08. Estimated completion is 2019-01-01.
What conditions does trial NCT03214120 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
Who is sponsoring clinical trial NCT03214120?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03214120 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.